HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Heras-Garvin Selected Research

Synucleins

11/2021ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
1/2021The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders.
1/2021Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease.
1/2020High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy.
1/2020Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance.
11/2019The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.
1/2019Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Heras-Garvin Research Topics

Disease

9Multiple System Atrophy
11/2021 - 03/2016
4Neurodegenerative Diseases (Neurodegenerative Disease)
11/2021 - 01/2020
4Synucleinopathies
11/2021 - 01/2020
4Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2020
2Dementia (Dementias)
01/2021 - 01/2020
1Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy)
11/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Neuroinflammatory Diseases
01/2020
1Multiple Sclerosis
01/2020
1Inflammation (Inflammations)
01/2020
1Gliosis
01/2020
1Proteostasis Deficiencies
01/2019

Drug/Important Bio-Agent (IBA)

7SynucleinsIBA
11/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2020
23- (1,3- benzodioxol- 5- yl)- 5- (3- bromophenyl)- 1H- pyrazoleIBA
01/2020 - 01/2019
1ATH434IBA
11/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1ChemokinesIBA
01/2020
1SaltsIBA
01/2020
1CytokinesIBA
01/2020
1PrionsIBA
03/2016

Therapy/Procedure

1Therapeutics
01/2020